1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Ralitza Gavrilova: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy Nicotinamide Riboside, Placebo - Mitochondrial Myopathy | Phase 2 | Active not recruiting | Ralitza Gavrilova | 34 | 2023-05-26 | 2026-01-26 |
| (+) Epicatechin to Treat Friedreich's Ataxia (+)-Epicatechin - Friedreich's Ataxia | Phase 2 | Completed | Ralitza Gavrilova | 10 | 2016-09-01 | 2019-12-05 |
Friedreich Ataxia (1) · Mitochondrial Myopathies (1)
Catechin (1) · nicotinamide-beta-riboside (1)
United States (2)
Ralitza H Gavrilova, MD (1) · Ralitza H. Gavrilova, MD (1)